Skip to main content
. 2021 Dec 13;8:756707. doi: 10.3389/fmed.2021.756707

Table 1.

Bivariate categorical comparisons.

Treatment Control Overall
(N = 104) (N = 96) (N = 200) P-value
Gender 0.999
    Female 64 (61.5%) 59 (61.5%) 123 (61.5%)
    Male 40 (38.5%) 37 (38.5%) 77 (38.5%)
Cardiovascular disease 0.999
    No 13 (12.5%) 3 (3.1%) 16 (8.0%)
    Yes 91 (87.5%) 93 (96.9%) 184 (92.0%)
Diabetes 0.251
    No 66 (63.5%) 53 (55.2%) 119 (59.5%)
    Yes 38 (36.5%) 43 (44.8%) 81 (40.5%)
COPD 0.033
    No 49 (47.1%) 60 (62.5%) 109 (54.5%)
    Yes 55 (52.9%) 36 (37.5%) 91 (45.5%)
Chronic renal failure 0.069
    No 84 (80.8%) 87 (90.6%) 171 (85.5%)
    Yes 20 (19.2%) 9 (9.4%) 29 (14.5%)
Recent cancer 0.825
    No 93 (89.4%) 84 (87.5%) 177 (88.5%)
    Yes 11 (10.6%) 12 (12.5%) 23 (11.5%)
Alcohol 0.347
    No 78 (75.0%) 66 (68.8%) 144 (72.0%)
    Yes 26 (25.0%) 30 (31.2%) 56 (28.0%)
Coffee 0.557
    No 14 (13.5%) 16 (16.7%) 30 (15.0%)
    Yes 90 (86.5%) 80 (83.3%) 170 (85.0%)
Tobacco 0.448
    No 97 (93.3%) 86 (89.6%) 183 (91.5%)
    Yes 7 (6.7%) 10 (10.4%) 17 (8.5%)
Symptomatic Covid-19 0.015
    No 102 (98.1%) 86 (89.6%) 188 (94.0%)
    Yes 2 (1.9%) 10 (10.4%) 12 (6.0%)
Covid mortality 0.480
    No 104 (100%) 95 (99.0%) 199 (99.5%)
    Yes 0 (0%) 1 (1.0%) 1 (0.5%)